LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) OverviewTrack LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s EBIT ($-360M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024
As of the most recent data (March 2024), YSBPW shows a EBIT of $-360M. That is below the sector sector average of $-26M. Scroll down for historical charts and peer comparison views.
The its sector sector average EBIT is about $-26M. LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is at $-360M, which is lower that average. That is roughly 1283.6% below the sector mean. Use the comparison chart on this page to see how YSBPW stacks up against individual peers as well.
Tracking YSBPW's ebit over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $-360M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-360M) with ownership activity and broader fundamentals.
